T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice

Annals of the Rheumatic Diseases

Volumn 66, Issue 5, 2007, Pages 599-604

  Von Delwig, Alexei ^a   Altmann, Daniel M ^b   Charlton, Fraser G ^c   McKie, Norman ^a   Isaacs, John D ^a   Holmdahl, Rikard ^d   Robinson, John H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; FREUND ADJUVANT; HLA DR ANTIGEN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; DENDRITIC CELL; FOOT PAD; GLYCOSYLATION; HISTOLOGY; HYBRIDOMA; IMMUNIZATION; LYMPH NODE CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SPLEEN; SWELLING; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL DIVISION; CELLS, CULTURED; COLLAGEN TYPE II; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GLYCOSYLATION; HINDLIMB; HLA-A ANTIGENS; HUMANS; HYBRIDOMAS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 34248151001     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.061945     Document Type: Article

References (30)

1. de Vries RRP, Huizinga TWJ, Toes REM. Redefining the HLA and RA association: to be or not to be anti-CCP positive. Autoimmunity 2005;25:21-5.
2. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976;57:1148-57.
3. Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, Wooley P, et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol 2001;166:1492-8.
4. Brownlie RJ, Myers LK, Wooley PH, Corrigall VM, Bodman-Smith MD, Panayi GS, et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum 2006;54:854-63.
5. Zanelli EH, Breedveld FC, de Vries RRP. HLA class II association with rheumatoid arthritis: facts and interpretations. Hum Immunol 2000;61:1254-61.
6. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
7. Harney SM, Newton JL, Wordsworth BP. Molecular genetics of rheumatoid arthritis. Arthritis Rheum 2003;3:280-5.
8. Holmdahl R, Bockermann R, Bäcklund J, Yamada H. The molecular pathogenesis of collagen-induced arthritis in mice - a model for rheumatoid arthritis. Ageing Res Rev 2002;1:135-47.
9. Brunsberg U, Gustafsson K, Jansson L, Michaëlsson E, Ahrlund-Richter H, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994;24:1698-702.
10. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 1997;61:1861- 78.
11. Holmdahl R. Dissection of the genetic complexity of arthritis using animal models. Immunol Lett 2006;103:86-91.
12. Rosloniec EF, Brand DD, Myers LK, Whiltington KB, Gumanovskaya M, Zaller DM, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997;185:1113-22.
13. Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whiltington KB, Zaller DM, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1 *0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998;160:2573-8.
14. Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, et al. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA 1998;95:7574-9.
15. Fugger L, Rothbard JB, Sonderstrup-McDevitt G. Specificity of an HLA-DRB1 *0401-restricted T cell response to type II collagen. Eur J Immunol 1996;26:928-33.
16. Rosloniec EF, Whittington KB, Zaller DM, Kang AH. HLA-DR1 (DRB1 *0101) and DR4 (DRB1 *0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J Immunol 2002;168:253-9.
17. Bäcklund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002;99:9960-5.
18. Michaëlsson E, Malmström V, Reis S, Engström Å, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994;180:745-9.
19. Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002;32:3776-84.
20. Holm B, Baquer SM, Holm L, Holmdahl R, Kihlberg J. Role of the galactosyl moiety of collagen glycopeptides for T-cell stimulation in a model for rheumatoid arthritis. Bioorg Med Chem 2003;11:3981-7.
21. Altmann DM, Douek DC, Frater AJ, Hetherington CM, Inoko H, Elliott JI. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med 1995;181:867-75.
22. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-66.
23. von Delwig A, Altmann DM, Isaacs JD, Harding CV, Holmdahl R, McKie N, et al. The impact of glycosylation on HLA-DR1 restricted T cell recognition of type II collagen in a mouse model. Arthritis Rheum 2006;54:482-91.
24. von Delwig A, Hilkens CMU, Altmann DM, Holmdahl R, Isaacs JD, Harding CV, et al. Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. Arthritis Res Ther 2006;8:R93.
25. Delvig AA, Robinson JH, Wetzler LM. Testing meningococcal vaccines for mitogenicity and superantigenicity. In: Pollard A J, Maiden MC, eds. J Meningococcal vaccines Methods and protocols.66. Totowa, NJ: Humana Press, 2001:199-221.
26. Holmdahl M, Grubb A, Holmdahl R. Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. Int Immunol 2004;16:717-26.
27. Manoury-Schwartz B, Chiocchia G, Lotteau V, Fournier C. Selective increased presentation of type II collagen by leupeptin. Int Immunol 1997;9:581-9.
28. P molecules. Eur J Immunol 1998;28:755-67.
29. Hassell AB, Plant MJ, Clarke S, Fisher J, Jones PW, Saklatvala J, et al. Small joint synovitis in rheumatoid arthritis: should it be assessed separately? Br J Rheumatol 1995;34:51-5.
30. Kim HY, Kim WU, Cho ML, Lee SK, Joun J, Kim SI, et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2085-93.